Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: Results from a combined analysis of 4 randomized clinical trials

JACC: Heart Failure

Volumn 2, Issue 6, 2014, Pages 623-629

  Steinberg, Benjamin A ^a,b   Al Khatib, Sana M ^a,b   Edwards, Rex ^b   Han, JooYoon ^c   Bardy, Gust H ^c,d   Bigger, J Thomas ^e   Buxton, Alfred E ^f   Moss, Arthur J ^g   Lee, Kerry L ^b   Steinman, Richard ^e   Dorian, Paul ^h   Hallstrom, Alfred ^c   Cappato, Riccardo ⁱ   Kadish, Alan H ^j   Kudenchuk, Peter J ^c   Mark, Daniel B ^a,b   Inoue, Lurdes Y T ^c   Sanders, Gillian D ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Seattle Institute for Cardiac Research   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ IRCCS POLICLINICO SAN DONATO   (Italy)

^j NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

Comorbid illness; Implantable cardioverter defibrillator; Outcomes; Randomized trials

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; SUDDEN CARDIAC DEATH; SURVIVAL RATE; COMPLICATION; DEATH, SUDDEN, CARDIAC; HEART STROKE VOLUME; META ANALYSIS; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84926220128     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.06.007     Document Type: Article

References (20)

1. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. NEngl J Med 1996, 335:1933-1940.
2. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G. Arandomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. NEngl J Med 1999, 341:1882-1890.
3. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. NEngl J Med 2002, 346:877-883.
4. Kadish A., Dyer A., Daubert J.P., et al. Prophylacticdefibrillator implantation in patients with nonischemic dilated cardiomyopathy. NEngl J Med 2004, 350:2151-2158.
5. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. NEngl J Med 2005, 352:225-237.
6. Mushlin A.I., Hall W.J., Zwanziger J., et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation 1998, 97:2129-2135.
7. Sanders G.D., Hlatky M.A., Owens D.K. Cost-effectiveness of implantable cardioverter-defibrillators. NEngl J Med 2005, 353:1471-1480.
8. Albert C.M., Quigg R., Saba S., et al. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. Am Heart J 2008, 156:367-372.
9. Huang D.T., Sesselberg H.W., McNitt S., et al. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. JCardiovasc Electrophysiol 2007, 18:833-838.
10. Charytan D.M., Patrick A.R., Liu J., et al. Trendsinthe use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 2011, 58:409-417.
11. Goldenberg I., Moss A.J., McNitt S., et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006, 98:485-490.
12. Chan P.S., Nallamothu B.K., Spertus J.A., et al. Impact of age and medical comorbidity on theeffectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2009, 2:16-24.
13. Lee K.L., Hafley G., Fisher J.D., et al. Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation 2002, 106:233-238.
14. Levey A.S., Stevens L.A., Schmid C.H., et al. Anew equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
15. Lunn D.J., Thomas A., Best N., Spiegelhalter D. WinBugs-a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000, 10:325-337.
16. Masoudi F.A., Go A.S., Magid D.J., et al. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes 2012, 5:e78-e85.
17. Al-Khatib S.M., Hellkamp A., Bardy G.H., et al. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA 2013, 309:55-62.
18. Lee D.S., Tu J.V., Austin P.C., et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. JAm Coll Cardiol 2007, 49:2408-2415.
19. Parkash R., Stevenson W.G., Epstein L.M., Maisel W.H. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J 2006, 151:397-403.
20. Brodsky M.A., McAnulty J., Zipes D.P., Baessler C., Hallstrom A.P. Ahistory of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study. Am Heart J 2006, 152:724-730.